These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16889434)

  • 1. Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate.
    Murakami T; Fan J; Yudasaka M; Iijima S; Shiba K
    Mol Pharm; 2006; 3(4):407-14. PubMed ID: 16889434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.
    Murakami T; Sawada H; Tamura G; Yudasaka M; Iijima S; Tsuchida K
    Nanomedicine (Lond); 2008 Aug; 3(4):453-63. PubMed ID: 18694307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dispersion of cisplatin-loaded carbon nanohorns with a conjugate comprised of an artificial peptide aptamer and polyethylene glycol.
    Matsumura S; Ajima K; Yudasaka M; Iijima S; Shiba K
    Mol Pharm; 2007; 4(5):723-9. PubMed ID: 17685580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery.
    Li N; Zhao Q; Shu C; Ma X; Li R; Shen H; Zhong W
    Int J Pharm; 2015 Jan; 478(2):644-54. PubMed ID: 25510600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-walled carbon nanohorns as drug carriers: adsorption of prednisolone and anti-inflammatory effects on arthritis.
    Nakamura M; Tahara Y; Ikehara Y; Murakami T; Tsuchida K; Iijima S; Waga I; Yudasaka M
    Nanotechnology; 2011 Nov; 22(46):465102. PubMed ID: 22024636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
    Murakami T; Ajima K; Miyawaki J; Yudasaka M; Iijima S; Shiba K
    Mol Pharm; 2004; 1(6):399-405. PubMed ID: 16028351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.
    Yokoe J; Sakuragi S; Yamamoto K; Teragaki T; Ogawara K; Higaki K; Katayama N; Kai T; Sato M; Kimura T
    Int J Pharm; 2008 Apr; 353(1-2):28-34. PubMed ID: 18082345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization of a carbon nanomaterial-based localized drug-release system using a bispecific material-binding peptide.
    Kokubun K; Matsumura S; Yudasaka M; Iijima S; Shiba K
    Int J Nanomedicine; 2018; 13():1643-1652. PubMed ID: 29588591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery.
    Wen H; Dong C; Dong H; Shen A; Xia W; Cai X; Song Y; Li X; Li Y; Shi D
    Small; 2012 Mar; 8(5):760-9. PubMed ID: 22228696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery.
    Liu Z; Sun X; Nakayama-Ratchford N; Dai H
    ACS Nano; 2007 Aug; 1(1):50-6. PubMed ID: 19203129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded (PEG)₃-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study.
    Ayen WY; Garkhal K; Kumar N
    Mol Pharm; 2011 Apr; 8(2):466-78. PubMed ID: 21288047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of carbon nanohorn agglomeration using a conjugate composed of comb-shaped polyethylene glycol and a peptide aptamer.
    Matsumura S; Sato S; Yudasaka M; Tomida A; Tsuruo T; Iijima S; Shiba K
    Mol Pharm; 2009; 6(2):441-7. PubMed ID: 19718797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
    Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
    Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of liposomal phospholipids and lipid transport-related protein on the intracellular fate of encapsulated doxorubicin.
    Un K; Sakai-Kato K; Kawanishi T; Okuda H; Goda Y
    Mol Pharm; 2014 Feb; 11(2):560-7. PubMed ID: 24383572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.